EMAIL THIS PAGE TO A FRIEND

Journal of pharmacological sciences

Total glucosides of paeony attenuate renal tubulointerstitial injury in STZ-induced diabetic rats: role of Toll-like receptor 2.


PMID 24739281

Abstract

Accumulating evidence suggested that macrophages induce tubulointerstitial injury. Total glucosides of paeony (TGP), extracted from Paeonia lactiflora, has presented anti-inflammatory activities in diabetic kidney disease. This research will investigate the protective effect of TGP on renal tubulointerstitium and its mechanism in streptozotocin-induced diabetic rats. TGP was administered orally at a dose of 50, 100, and 200 mg·kg(-1)·d(-1) for 8 weeks. Tubulointerstitial injury was quantified, followed by immunohistochemistry analysis of renal α-smooth muscle actin (α-SMA), E-cadherin (E-cad) expression, nuclear factor kappa B (NF-κB)-p-p-65(+), Toll-like receptor (TLR)2(+), and ED-1(+) cell infiltration in renal tubulointerstitium. Renal TLR2(+) macrophages were detected by double immunohistochemical staining. Western blotting was used to detect the TLR2 expression. Histologically, there was marked accumulation of TLR2(+), NF-κB-p-p-65(+), ED-1(+) cells, and ED-1(+)TLR2(+) cells (macrophages) in the diabetic kidney and TGP treatment could alleviate it. Accompanying with that, the tubulointerstitial injury was ameliorated, α-SMA expression was lower, and E-cad expression was higher compared with the diabetic rats. Western blot analysis showed that the expression of TLR2 protein was significantly increased in the kidney of the diabetic rats, whereas TGP treatment reduced it. Our study showed that TGP could prevent renal tubulointerstitium injury in diabetic rats through a mechanism that may be at least partly correlated with suppression of increased macrophage infiltration and the expression of TLR2.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW22787 Anti-TLR2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
PRS3135
Anti-TLR2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
C3021
Dicyanocobinamide, ≥93%
C50H72CoN13O8
WH0007097M7
Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E7, purified immunoglobulin, buffered aqueous solution
SAB1404474
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2G9, purified immunoglobulin, buffered aqueous solution
SAB1409745
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2A3, purified immunoglobulin, buffered aqueous solution
SAB1409746 Monoclonal Anti-TLR2 antibody produced in mouse, clone 2D2, purified immunoglobulin, buffered aqueous solution
SAB1409747 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3F10, purified immunoglobulin, buffered aqueous solution
SAB1409748 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E3, purified immunoglobulin, buffered aqueous solution
SAB1409749 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4D6, purified immunoglobulin, buffered aqueous solution
SAB1409750 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4G9, purified immunoglobulin, buffered aqueous solution
SAB1409751 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1C6, purified immunoglobulin, buffered aqueous solution
SAB1409752 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1B10, purified immunoglobulin, buffered aqueous solution
SAB1409753 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4C4, purified immunoglobulin, buffered aqueous solution
SAB1409754 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3H8, purified immunoglobulin, buffered aqueous solution
SAB1409755 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4H6, purified immunoglobulin, buffered aqueous solution